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When binding of 1251-alpha bungarotoxin (1Z51-(rBTX) to hypo- 
thalamic membranes is observed over a wide range of concen- 
trations, 3 binding sites can be identified, with estimated equi- 
librium dissociation constants (Z&s) of 4.1 x 10-l] M, 6.2 x 
lo-lo M, and 9.1 x lo-’ M for high-, low-, and very-low-affinity 
interactions, respectively. The densities of the high- and low- 
ail’inity sites were similar at 14-21 fmol/mg protein, whereas 
the very-low-affinity site had approximately 1000 x greater ca- 
pacity. Association and dissociation kinetics predicted a bi- 
phasic binding reaction, with association rate constants of 1.38 x 
lo* M-I min-’ and 7.53 x 10’ M-* min-’ and dissociation rate 
constants of 5.23 x 1O-3 min-1 and 1.80 x 1O-3 min-I. The 
presence of Na+ inhibited the binding of Y-orBTX with a half- 
maximally effective concentration of 22 mM. This decrease in 
binding was associated with the observation of a single binding 
site with a K,, of 4.3 x lo-lo M and a density of 12.1 fmol/mg 
protein. In competition binding experiments, aBTX, curare, nic- 
otine, and quinacrine were the most potent competitors. Ace- 
@choline competed with ‘*%aBTX binding at 2 sites with es- 
timated affinities of 3.6 x 1O-s and 7.4 x 1O-5 M. In the rostra1 
hypothalamus, high-affinity binding of 1251-~BTX was localized 
to the region of the supraoptic nucleus, paraventricular nucleus, 
suprachiasmatic nucleus, and the nucleus circularis complex. 
Within magnocellular regions, binding was closely associated 
with neurophysin-immunoreactive neurons and processes, while 
in the region of the suprachiasmatic nucleus, the binding was 
in a perinuclear region surrounding parvocellular neurophysin- 
immunoreactive neurons. 
It is now well recognized that the central nervous system pos- 
sesses an alpha bungarotoxin-binding protein that is biochem- 
ically and pharmacologically similar to the nicotinic acetylcho- 
line receptor (nAChR) of electric eel and muscle (Conti-Tronconi 
et al., 1985; Dolly and Barnard, 1984; Lowy et al., 1976; Morley, 
1981; Oswald and Freeman, 198 1). The binding of *ZSI-alpha- 
bungarotoxin (1251-(rBTX) shows selectivity for ACh-sensitive 
neurons in vitro (Carbonetto et al., 1978; Chalazonitis et al., 
1974; Greene et al., 1973), is associated with synaptosomes 
(Salvaterra et al., 1975) and can be localized to the postsynaptic 
region (Hunt and Schmidt, 1978a; Lentz and Chester, 1977; 
Marshall, 1981; Smolen, 1983; Vogel et al., 1977). A reliable 
pattern of 12SI-aBTX binding has been observed in the brain, 
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the highest overall concentration of sites generally being in the 
hypothalamus (Hunt and Schmidt, 1978b Marks and Collins, 
1982; Morley et al., 1977; Segal et al., 1978). Various affinities 
for the binding of lZ51-~BTX to brain membranes have been 
reported, they range from equilibrium (or kinetic) dissociation 
constants (KJ as low as 0.4-3 x lO-‘O M (Lukas, 1984b, Marks 
and Collins, 1982; Morley et al., 1977; Salvaterra and Mahler, 
1976; Schmidt, 1977; Wang et al., 1978) to intermediate values 
of l-5 x 1O-9 M (Lukas, 1984a, b; Patrick and Stallcup, 1977a; 
Salvaterra et al., 1975) and finally to the high values of l-40 x 
1O-8 M (Lukas, 1984b; Salvaterra, et al., 1975). Each of these 
sites has nAChR-like pharmacology. Given these results, it is 
not surprising that several investigators have suggested the pres- 
ence of multiple binding sites for lZSI-~BTX in the central ner- 
vous system (Lukas, 1984b; Morley et al., 1983; Schmidt, 1977). 
The above data from binding analyses provide a striking con- 
trast to those experiments in which olBTX has been unable to 
block the functional activation of the nAChR in spinal cord 
(Duggan et al., 1976), sympathetic ganglion (Chou and Lee, 
1969) and PC12 cells (Patrick and Stallcup, 1977b). Efforts to 
clarify such discrepancies by precipitating the 1251-aBTX-bind- 
ing protein with monoclonal antibodies to the purified nAChR 
have yielded mixed results, with some investigators successfully 
immunoprecipitating the 1251-cuBTX-binding protein (Block and 
Billiar, 1979; Dolly and Barnard, 1984) while others have been 
unsuccessful (Patrick and Stallcup, 1977b). Thus, the precise 
identity of the cYBTX-binding protein remains questionable. This 
issue is particularly important for the understanding of the role 
of the cholinergic network which is thought to control the release 
of vasopressin or oxytocin. The release of vasopressin is well 
recognized as being induced by nicotinic cholinergic agonists 
(Volle and Koelle, 1975) and the system that mediates this 
response is probably contained within the rostra1 hypothalamus 
(Sladek, 1983). Further support for this possibility is provided 
by the high binding of 12SI-aBTX in the hypothalamus (Marks 
and Collins, 1982; Morley et al., 1977; Segal et al., 1978) and 
particularly the supraoptic nucleus (NSO) of the hypothalamus 
(Hunt and Schmidt, 1978b; Polz-Tejera et al., 1975; Silver and 
Billiar, 1976). Electrophysiological evidence indicates that the 
cells responsive to nicotinic cholinergic agonists may be the 
same as or similar to the cells that synthesize vasopressin in the 
NSO of the hypothalamus (Amauld et al., 1983; Barker et al., 
197 1; Bioulac et al., 1978; Gahwiler and Dreifuss, 1980; Sakai 
et al., 1974). Thus, a nicotinic cholinergic synapse within the 
NSO may be an important link in the neural mechanisms that 
control the secretion of vasopressin. 
In an effort to evaluate the significance of the binding of lZ51- 
olBTX in the NSO and the possible presence of nAChRs, we 
have characterized pharmacologically the binding of lZSI-aBTX 
in the hypothalamus. A procedure for combining receptor au- 
toradiography and immunocytochemistry on a single free-float- 
ing section allowed assessment of the codistribution of neuro- 
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physin-immunoreactive neurons and aBTX binding sites. 
Three ‘251-~BTX binding sites, with Kds ranging from 4.1 x 
10-l’ to 4.0 x lo-’ M, can be discriminated in the brain. The 
high-affinity sites have nicotinic cholinergic pharmacology, a 
half-time on the receptor of 2-6 hr, and are sensitive to the 
cation concentration in the buffer. These high-affinity sites are 
localized to the region of the NSO, suprachiasmatic nucleus 
(NSC), paraventricular nucleus (NPV), and nucleus circularis 
(NC). A high correlation of this binding distribution with neu- 
rophysin-immunoreactive magnocellular neurons suggests that 
these binding sites may have a special relevance for the func- 
tional organization of the vasopressin/oxytocin neurosecretory 
system. 
Materials and Methods 
Materials 
Monoiodinated 12+orBTX was obtained from New England Nuclear at 
an initial specific activity of 16.5-17.6 rCi/pg (261-279 cpm/fmol). All 
cholinergic ligands were obtained from Sigma. Normal goat serum was 
purchased from Antibodies Incorporated. Tetramethylrhodamine iso- 
thiocyanate-conjugatedgoat anti-rabbit IgG (TRITC-CAR, lot no. 15967) 
was purchased from Cappel. The specific RN4 neurophysin antibody 
(Reaves et al.. 1983: Sokol et al.. 1976) was the generous sift of Dr. 
Alan Robinson, University of Pittsburgh (Grant-AM- 16 166). Other 
materials were of reagent or comparable quality and were from standard 
sources. 
Preparation of membranes for lZ51-(rBTX binding 
Male Sprague-Dawley rats were lightly anesthetized with sodium pen- 
tobarbital (30 mg/kg). Each rat was then killed by decapitation; the 
brain was rapidly removed and immersed in ice-cold 0.32 M sucrose. 
The hypothalamus and brain stem were dissected from the brain on ice 
(Hayward et al., 1983). Washed membranes from each region were 
prepared by homogenizing the tissue in 10 vol of 0.32 M sucrose. The 
resulting homogenate was centrifuged at 600 x g for 10 min, the pellet 
discarded, the membrane suspension diluted to a volume of 40 ml with 
assay buffer (10 mM phosphate buffer, 1 mM EDTA, 0.1 mM phenyle- 
thylsulfonyl flouride, 0.02% sodium azide) and centrifuged at 39,000 x 
g for 20 min. The resulting pellet was resuspended in 40 ml assay buffer 
and again centrifuged at 39,000 x g. After a total of 3 washes, the tissue 
was resuspended in assay buffer at a concentration of 100-200 mg/ml 
and aliquots stored frozen at -80°C. Binding of 1251-(uBTX to the frozen 
membranes did not differ from that to fresh tissue, and remained stable 
for at least 1 month. 
Characterization of jz51-aBTX binding 
Washed membranes were diluted in assay buffer at concentrations rang- 
ing from 5 to 50 mg wet wt/ml. A 400 ~1 aliquot of membranes (2-20 
mg wet weight) was added to polypropylene tubes containing 6-1000 
PM lZSI-~BTX and an appropriate concentration of competing drug or 
buffer. Final assay volume was 0.5 ml. Tubes were incubated at 22°C 
for 2.5 hr. The reaction was terminated by adding 10 ml of wash buffer 
(10 mM phosphate-buffered saline, 0.5% gelatin, pH 7.4), followed by 
rapid filtration through Schleicher and Schuell no. 30 glass fiber filters. 
Each filter was washed twice with 100 ml of wash buffer. The dry filters 
were transferred to 13 x 100 mm tubes and counted in a Tracer gamma 
counter at an efficiency of 85-90%. This procedure was effective in 
reducing any nonspecific binding of ‘Y-~uBTX to the glass fiber filters 
to less than 1% of the total counts added at the highest ligand concen- 
trations. These filter blanks were constant within each experiment and 
were subtracted from the total binding values. Attempts to reduce non- 
specific filter binding with other compounds, including serum albumins, 
poly+-lysine, 0.5 M NaCl, and Prosil (Harden et al., 1983), were less 
effective. Nonspecific binding to tissue ranged from 10 to 50% of the 
total binding, depending on the concentration of lZSI-aBTX in the assay. 
Both total and nonspecific binding of *251-(rBTX to rat brain membranes 
were found to be unaffected by pH in the range of 7.0-8.2. Results 
obtained with the filtration binding assay were the same as those of 
experiments utilizing a centrifugation assay protocol. Protein determi- 
nations were made on samples of the tissue homogenates according to 
the method of Lowry et al. (195 1). 
A protocol similar to the above was followed for the binding of 12sI- 
(YBTX to 50 pm sections of hypothalamus, with the following exceptions: 
(1) Sections were washed in an excess ofassay buffer and then transferred 
to a 24-well tissue culture plate containing 12SI-~BTX in a final assay 
volume of 1 ml. (2) Binding was terminated by transferring the sections 
through 3 successive 2 min washes in 2 ml of wash buffer and, finally, 
into a 13 x 100 mm test tube containing 0.5 ml assay buffer. Each 
section was immediately counted for 1 min in a Tracer gamma counter 
and then quickly mounted onto a gelatin-chrome alum-coated glass 
slide and dried in preparation for autoradiography. 
Data analysis 
Computer analysis of the data from saturation binding and competition 
binding experiments was accomplished by using either a Gauss-Newton 
or Marquart nonlinear least-squares regression program that required 
a minimum of approximately 15 data points per curve. Since highly 
accurate values are difficult to obtain with nonspecific binding and other 
potential sources of variability exceeding 10% of the total binding, such 
values should be considered estimates, particularly for the low-affinity 
site. Error values for replicate determinations of Kg were &3 1% and 
? 102% for the high- and low-affinity sites, respectively. Estimates for 
both the high- and low-affinity B,,, values were replicated to within 
f  17%. The saturation binding nonlinear regression was based on the 
equation, 
B mar, x L Lx2 x L B=-+- 
L + Kc+, L x &z 
where B = total ligand specifically bound, L = ligand concentration, 
Kd, = dissociation constant for the high-affinity site, B-, = density of 
the high-affinity site, Kdl = dissociation constant for the low-affinity site, 
and Bm = density of the low-affinity site. 
Competition binding nonlinear regression analysis was based on the 
equation, 
Fractional occupancy = % x Y$&- 
T 50.1 
B L +sx- 
4 L + G,, 
where BT = total ligand bound, L = ligand concentration, IC,,, = con- 
centration of drug that inhibits half the high-affinity binding, IC,,, = 
concentration of drug that inhibits half the low-affinity binding, B,,, = 
relative density of high-affinity sites, and Bmax2 = relative density of low- 
affinity sites. 
Inhibition constants (K,s) from competition binding experiments were 
calculated from ZC,, values according to Cheng and Prusoff (1973): 
IGO K1 = - 
1 + F/K, 
where IC,, = the concentration of drug that inhibits half the ligand 
binding, F = the free molar concentration of the ligand, and K,, = the 
dissociation constant of the ligand. Conditions for competition binding 
were generally established such that the majority of the ligand binding 
was to the high-affinity site. Consequently, the high-affinity K,, estimates 
were used for the calculation of the inhibition constants. 
Combined receptor autoradiography and neurophysin 
immunocytochemistry 
Male Sprague-Dawley rats were deeply anesthetized with sodium pen- 
tobarbital (60 mg/kg). The chest cavity was opened and the rat was 
rapidly perfused through the heart with a balanced salt solution (50 ml) 
followed by 0.5% paraformaldehyde in 50 mM PBS (200 ml, pH 7.4). 
The brain was removed, blocked, and postfixed overnight at 22°C in 
the same 0.5% paraformaldehyde solution. Free-floating 50 pm sections 
were cut on a vibrating microtome and then processed sequentially 
through the following solutions: (1) 0.01 mM PBS, pH 7.4, 5 min x 2, 
(2) 0.01 M PBS, 1% normal goat serum, 0.01% sodium azide, 10 min, 
(3) neurophysin antibody RN4 (1:2000), 16-24 hr at 4°C in PBS, 1% 
normal goat serum, 0.0 1% sodium azide, (4) 2 ml receptor-binding assay 
buffer, 5 min at 22°C x 3, (5) 1 ml binding assay buffer containing lO- 
1000 PM lZSI-aBTX and TRITC-CAR (1:200), 2.5 hr at 22”c, and (6) 
2 ml PBS, 2 min x 3. At the end of the labeling/binding procedure, 
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Figure 1. Saturation binding profile for the interaction of 12+aBTX 
with fresh, washed membranes from rat hypothalamus. Each assay tube, 
containing 360 pg tissue protein, was incubated with 13-4852 PM 1251- 
aBTX for 2.5 hr at 22°C. Top, Total (O), specific (0), and nonspecific 
(A) binding of ‘251-(rBTX is plotted as a function of the free 1251-aBTX 
concentration. Two-site analysis of the Scatchard curve for specific lZsI- 
(YBTX binding (bottom), using a Gauss-Newton nonlinear regression 
curve-fitting procedure, resulted in Kd estimates of 4.1 x 10-l! M and 
6.2 x lo-lo M for the high- and low-affinity sites, respectively. Estimates 
of &ax were 2 1.1 and 13.9 fmol/mg protein for the high- and low- 
affinity sites, respectively. Nonspecific binding was determined in the 
presence of 1O-5 M (U~~~. 
Brainstem 
50 100 150 
BOUND (fmales/ml) 
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Figure 2. Saturation binding profile for the interaction of lZSI-~BTX 
with washed membranes prepared from rat brain stem. Specific binding 
of 124-(uBTX to 820 pg tissue protein is plotted as a function of free 
ligand concentration from 6 to 7721 PM (top). Nonlinear regression 
analysis of the Scatchard curve (bottom) resulted in Kd estimates of 
2.2 x lo-l1 M and 2.8 x lO-9 M for the high- and low-affinity sites, 
respectively. Estimates of B,,, were 17.6 and 25.8 fmoVmg protein. 
Nonspecific binding was determined in the presence of 10 mM ACh. 
Dilution in IO-* M a-BTX 
t 
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Figure 3. Time course for the association (0) and dissociation (0) of 
1Z51-aBTX on membranes prepared from rat brain. Tissue (338 pg pro- 
tein) was incubated in 0.5 ml assay buffer containing 182 PM 1251-(rBTX 
for the times indicated. After 3 hr, membranes were diluted in 20-fold 
excess assay buffer containing lo-* M (YBTX. The dissociation process 
was terminated at the indicated times by rapid filtration and washing 
of the membranes. 
each section was counted and prepared for autoradiography, as de- 
scribed above. Nonspecific binding values determined in the presence 
of excess d-tubocurarine, nicotine, or acetylcholine were all found to 
give comparable results (approximately 20-40% nonspecific binding). 
The wet weight of the sections used for this assay averaged 0.580 & 
0.052 mg and contained approximately 52.7 pg of protein. 
Autoradiography 
Slides containing 50 pm sections of hypothalamus were dipped in Kodak 
NTB-2 emulsion at 45°C in total darkness. The emulsion-coated slides 
were allowed to dry at room temperature and were then transferred to 
sealed, desiccated slide boxes, where they were exposed at 4°C for a 
period of 14-28 d (2000-4000 cpm x d). At the end of the exposure 
period, the emulsion was developed in Kodak D- 19 (1: 1) for 4 min, 
washed in distilled water for 10 set, and fixed in Kodak fixer for 5 min. 
Sections were examined unstained or lightly counterstained in Pyronin 
Y according to the following procedure: (1) Distilled water, 5 dips. (2) 
Citric acid-sodium phosphate buffer, 20 mM, pH 5.6, 5 dips. (3) 0.2% 
Pyronin Y in citrate-phosphate buffer, 5 dips. (4) Citrate-phosphate 
buffer, 5 dips. (5) Distilled water, 5 dips x 2. The sections were then 
dehydrated in 50, 70, 80, 95, and 100% ethanol (2 min each), cleared 
in xylene, and coverslipped with Permount. The distribution of silver 
grains was examined and photographed on a Leitz Orthoplan micro- 
scope under both bright- and dark-field illumination. 
Results 
Binding of low concentrations of lZ51-aBTX to rat 
brain membranes 
Binding of ‘251-aBTX to membranes from rat hypothalamus is 
linear over a range of at least OS-O.6 mg protein (data not 
shown). Saturation binding of lZSI-~BTX to hypothalamic mem- 
branes is illustrated in Figure 1. The binding profile is complex, 
appearing to approach saturation at 4 x lo-lo M 1251-(rBTX and 
then increasing again. A Scatchard analysis (Fig. 1, bottom) of 
the data indicated the presence of 2 binding sites. Nonlinear 
regression analysis (regression lines not shown) identified a high- 
affinity 12SI-tiBTX binding site, with a Kd of 4.1 x 10-l’ M and 
a maximum density (B,,,,,) of 2 1.1 fmol/mg protein, and a low- 
affinity site with a K,, of 6.2 x lo-lo M and a B,,, of 13.9 fmol/ 
mg protein. 
The characteristics of lZ51-(rBTX binding to membranes pre- 
pared from brain stem, illustrated in Figure 2, are qualitatively 
and quantitatively similar to those of membranes from hypo- 
thalamus. Two-site analysis of the biphasic binding profile pre- 
dicted Kds of 2.2 x 10-l’ M and 2.8 x 1O-9 M for the high- and 
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Figure 4. Transformed association and dissociation rate data from 
Figure 3. Top, Natural logarithmic transformation of the amount of 
Y-~uBTX bound at equilibrium (B,), divided by the difference between 
B, and the amount bound at each time point, B, on the association 
curve, plotted as a function of time. Approximately 80% of the bound 
lz51-(uBTX associates as a fast component and 20% as a slower com- 
ponent. The estimated association rate constants from the slope of each 
line are 1.38 x lo* M-I min-I and 7.53 x 10’ M-I min’ for the fast 
and slow components, respectively. Bottom, Natural logarithmic trans- 
formation of the amount of lz51-olBTX bound at each time point, B, 
relative to the amount bound at the beginning of the dissociation process 
(BJ. Approximately 60% of the total bound dissociates as a fast com- 
ponent and 40% as a slow component. Estimates of the dissociation 
rate constants are 5.23 x lo-’ min-l and 1.80 x lo-) min-l for the fast 
and slow components, respectively. 
low-affinity sites, respectively, and corresponding densities of 
17:6 and 25.8 fmol/mg protein. The presence of both high- and 
low-affinity binding sites throughout the brain was confirmed 
by the observation of similar curvilinear binding profiles to the 
hippocampus, amygdala, septum, and cortex. The regions var- 
ied only in the density of binding sites, with the hypothalamus 
having the highest density. The remaining regions all exhibited 
similar receptor densities. 
Kinetics of 12’I-~BTX binding 
The association and dissociation of 1251-aBTX on membranes 
is illustrated in Figure 3. Equilibrium is established after ap- 
proximately 2.5 hr at 22°C and is maintained for at least 18 hr. 
Dilution of the membranes in 20-fold excess assay buffer con- 
taining 1O-8 M (rBTX to halt the association process initiated a 
relatively rapid decline in the 1251-aBTX bound to the mem- 
branes. Analysis of the transformed data (Fig. 4) indicated the 
presence of a biphasic rate process for both the association and 
dissociation of 12SI-aBTX. Association rate (k,,) estimates yield- 
ed values of 1.38 x lo8 M-I min-I and 7.53 x lo7 M-I min-’ 
for the fast and slow components, respectively. Analysis of the 
dissociation process yielded rates of 5.23 x 1O-3 min-I and 
1.80 x 1O-3 min-’ for the fast and slow components, respectively 
(t,,* = 132 and 385 min, respectively). The fast component ac- 
counted for the majority of the association (80%), whereas the 
slow component accounted for approximately 60% of the total 
dissociation. 
Analysis of a very-low-a$inity 12’I-cuBTX binding site 
Recently, Lukas (1984b) described a binding site for 1251-aBTX 
in brain that had a Kd of 4 x lo-’ M. Since a site of such low 
0.2 0.3 0.4 0.5 
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Figure 5. Very-low-affinity binding of lz51-aBTX. Top, Saturation 
binding isotherm for the interaction of 0.54-476 nM 1251-iBTX (2 cpml 
fmol) with 240 IGZ ofbrain membrane urotein. Suecific bindine is olotted - . 
as a ‘function dfYZSI-cuBTX concentr&ion. Bottom, Scatchard analysis 
of the data illustrates binding of Y-aBTX to 2 sites. The very-low- 
affinity site has an estimated K, of 9 10 nM and a density of 28.1 pmol/ 
mg protein. Nonspecific binding was defined as binding in the presence 
of 5 mM ACh and varied from 24 to 42% of total binding. 
affinity could not be detected using our standard assay condi- 
tions, we reduced the specific activity of our 1251-(rBTX to l-2 
cpm/fmol by adding unlabeled aBTX. This specific activity was 
too low to measure the high-affinity binding of lZ51-~BTX. A 
saturation binding analysis (Fig. 5) confirmed the presence of a 
very-low-affinity binding site with a Kd of 9.1 x lo-’ M and a 
B,,, of 28.1 pmol/mg protein. Some binding to the low-affinity 
‘251-otBTX binding site was also measured under these condi- 
tions, yielding a curvilinear Scatchard plot. 
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Figure 6. Inhibition of lz51-aBTX binding as a function of increasing 
concentrations of Na+ in the assay buffer. Brain membranes (480 pg 
protein) were incubated in assay buffer containing 157 PM ‘*SxBTX 
and the indicated concentration of Na+ as the chloride salt. A total of 
2.23 fmol of Y-~uBTX was specifically bound in assay buffer (A,; 10 
mM Na+). The amount of 1251-~BTX snecifically bound in the presence 
of additional Na+ (A) relative to A, is plotted as a function of Na+ 
concentration. Nonspecific binding in the presence of 5 mM ACh was 
29% and 70% of total binding at 10 and 150 mM Na+, respectively. 
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Figure 7. Saturation binding analysis of the interaction of Y-(uBTX 
with brain membranes in the presence of 150 mM Na+. A total of 424 
pg of tissue protein was incubated with 32-2136 PM lz51-aBTX in assay 
buffer (0) or assay buffer containing 150 mM Na+ (0) for 2.5 hr at 22°C. 
Top, Specific binding of ‘W(UBTX is plotted as a function of free Y- 
otBTX concentration. Bottom, Scatchard analysis of the data illustrates 
2 binding components in the presence of 10 mM Na+ and a single binding 
component in the presence of 150 mM Na+. Nonspecific binding of 1251- 
olBTX in the presence of 10 mM ACh ranged from 18% of the total 
counts bound at low 1251-olBTX concentrations to 49% of the total counts 
bound at high concentrations. 
Efects of Na+ on i251-cuBTX binding 
The presence of increasing concentrations of NaCl in the assay 
buffer progressively inhibited the binding of iZ51-~BTX (Fig. 6) 
with a half-maximally effective concentration of 22 mM. The 
effect of Na+ on the affinity of rZ51-aBTX for its binding site is 
illustrated in Figure 7. In 150 mM Na+, the specific binding of 
1251-~uBTX exhibits a saturation binding profile typical of inter- 
action with a single site. Scatchard analysis of the data confirmed 
the presence of a single site with a Kd of 4.3 x lo-r0 M and a 
maximum density of 12.1 fmol/mg protein, approximately equal 
Table 1. Affinity of various compounds for the abungarotoxin 











Arginine vasopressin >lO 
Phenylmethylsufonylfuoride >lOO 
The bindina of each compound in competition with 1*51-aBTX was determined 
under standard assay conditions at concentrations of 149459 PM 12SI-aBTX. 
Under such conditions, the number of high-affinity sites occupied, relative to low- 
affinity sites, is greater than 5: 1. Inhibition constants (K,) were calculated according 
to Cheng and Prusoff (1973). Binding that could not be inhibited by the drugs 
represented 24 k 9% of total binding. 
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Figure 8. Competition binding curve for ACh in the presence of 5 17 
PM 1Z51-~BTX. Ligand bound in the presence of varying concentrations 
of ACh (B) relative to the amount bound in the absence of added 
competitor (B,; 750 cpm) is plotted as a function of the molar ACh 
concentration. Hill analysis of the binding data (inset) yielded a straight 
line (9 = 0.96) with a slope of -0.19. At the highest ACh concentration, 
64% of the total binding was displaced. Nonlinear regression analysis 
of the binding curve indicated the presence of at least 2 binding sites 
with apparent affinities for ACh of 3.6 + 2.8 x lo-* M and 7.4 ? 0.3 x 
1O-5 M. Binding was accomplished in the presence of 10 PM eserine and 
1 PM atropine to minimize degradation of the ACh and interaction with 
muscarinic receptors, respectively. Data represent the average of 2 ex- 
periments. SE for each data point, less than + 12%. 
to the density (15.2 fmol/mg protein) of the high-affinity site in 
the presence of 10 mM Na+. 
Comparison of the effects of the chloride salts of other mono- 
valent cations on the binding of iZ51-~BTX revealed a similar 
inhibitory effect. The following order of potency was found, 
based on the ability to inhibit 50% (ZC,,) of the total specific 





Figure 9. Concentration-dependent accumulation of rz51-aBTX on 50 
pm sections of rat hypothalamus. Hypothalamic sections containing 
approximately 53 pg of protein were incubated in 1 l-900 PM ‘*+(uBTX 
for 2.5 hr at 22°C. The saturation binding (top) and Scatchard curves 
(bottom) are the composite of 2 independent experiments (cirdes and 
triangles). Nonspecific binding was measured in the presence of 5 mM 
ACh. 
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Figure 10. Distribution of high-affinity 1Z51-otBTX binding sites in the rostra1 hypothalamus. A-E, Bright-field photomicrographs of uncounter- 
stained 50 pm sections illustrating the accumulation of silver grains after incubation in 54-l 11 PM ‘251-~BTX and processing for autoradiography. 
Sections were sampled at anterior-posterior coordinates of approximately A6400, A6200, A6 100, A6000, A5800, and A5900 for A-F, respectively, 
according to the coordinate system of Konig and Klippel(1963). Arrow, High density of labeling along the base of the NSO. F, Nonspecific binding 
of lz51-olBTX. The section is lightly counterstained with Pyronin Y to illustrate the location of the various nuclei. Exposure time, 28 d at 4°C. 
MagniJication, - 38 x . NSO, Supraoptic nucleus; NC, nucleus circularis complex; NSC, suprachiasmatic nucleus; OC, optic chiasm. 
26 mM) > Li+ (39 mM) > K+ (47 mM) > Cs+ (54 mM). Con- 
centrations of sucrose up to 150 mM had no effect on the binding 
of lz51-~BTX. 
Pharmacology of i2SI-aBTX binding 
The binding of a variety of ligands in competition with Y- 
aBTX is summarized in Table 1. The K, for each compound 
was calculated according to Cheng and Prusoff (1973) from the 
concentration at which half-maximal inhibition of binding oc- 
curs (ZC,,). The most potent competitor was LuBTX, followed 
by d-tubocurarine > nicotine, dimethylphenylpiperazinium, and 
quinacrine > ethopropazine, substance P, butyrlcholine, and 
acetylcholine > choline, arginine vasopressin, and phenylmeth- 
ylsulfonyl fluoride. These data must be interpreted cautiously, 
however, since Hill analyses of the data for ACh, LuBTX, d-tu- 
bocurarine, and dimethylphenylpiperazinium reveal slopes of 
0.2-0.5, indicating complex binding interactions. The com- 
plexity of the competition binding curve for ACh is illustrated 
in Figure 8. Hill analysis of the curve (Fig. 8, inset) yielded a 
slope of 0.2. A nonlinear regression analysis of the data indicates 
the presence of two binding sites. The high-affinity binding site 
(estimated K, = 3.6 x 1O-8 M) accounted for 31.4% of the total 
binding sites. The low-affinity binding site (estimated K, = 7.4 x 
1O-5 M) accounted for 68.6% of the total binding sites. 
The competition binding of ACh in the presence of 150 mM 
Na+, where the ‘251-olBTX is interacting with a single site, re- 
duced the complexity of the ACh binding profile. Inhibition of 
lz51-aBTX binding in the lo-91 O-6 M range was lost, yielding a 
steeper curve with a Hill coefficient of 0.53. 
Binding of 1z51-orBTX to hypothalamic sections from 
fixed brain 
Saturation binding and kinetic analyses of lZSI-aBTX binding 
to membranes prepared from 0.5% paraformaldehyde-fixed rat 
brain yielded results similar to those for unfixed membranes. 
The concentration-dependent accumulation of lZSI-aBTX 
achieved by free-floating 50 pm sections through the rostra1 
hypothalamus of the fixed rat brain is illustrated in Figure 9. A 
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Figure 1 I. Distribution of lZSI-(rBTX binding in relation to neurophysin-containing cells of the rostra1 hypothalamus. Hypothalamic sections were 
double-labeled by combining neurophysin immunocytochemistry with 12*I-~BTX binding under conditions optimal for both. NSO, NC, NSC, and 
NPV labeled at ligand concentrations of 103, 73, 29, and 111 PM, respectively. The first pair of photographs for each region (A-B, D-E, G-H, J- 
K) represents the same section under 548 nm incident illumination, for visualization of the TRITC-GAR-neurophysin complex (A, D, G, .I), or 
under dark-jield illumination for visualization of the overlying silver grains (B, E, H, K). Nonspecific binding of lz51-aBTX for the same region 
and concentration was determined on a separate section and is illustrated in the dark-field photomicrographs on the right (C, F, Z, L). Exposure 
time, 14 d at 4°C. Magnification, - 150 x for NSO, NC, and NPV, 375 x for NSC. NPK Paraventricular nucleus; IZZV, third ventricle; other 
abbreviations as in Figure 10. 
Scatchard analysis (Fig. 9, bottom) clearly illustrates the pres- 
ence of 2 binding components. Dissociation constants of 1.7 x 
IO-” and 2.0 x 10-l” M were calculated for the high- and low- 
affinity interactions, respectively. The density of the high-affin- 
ity site was approximately 1.6 fmol/section, while the density 
of the low-affinity site was approximately 6.1 fmol/section. 
Distribution of high-ajinity 12’I-~BTX binding sites in rat 
hypothalamus 
The hypothalamic distribution of lZSI-aBTX binding at concen- 
trations that predominantly label the high-affinity site is shown 
in Figure 10. The accumulation of 12SI-aBTX is highly selective 
for the region of the NSO, NSC, and the NC. Weaker labeling 
occurs in the NPV, and some scattered diffuse labeling in the 
lateral and anterior dorsal hypothalamus. We observed no con- 
sistent, anatomically discrete distribution of 12SI-~BTX that cor- 
related with low- and very-low-affinity binding sites. 
The close association of high-affinity lZ51-~BTX binding with 
neuroendocrine cells is illustrated by the high correlation be- 
tween the distribution of autoradiographic silver grains and neu- 
rophysin-immunoreactive cells on the same section. Examples 
of the distribution of 1251-~BTX in relation to neurophysin- 
immunoreactive cells for the NSO, NC, NSC, and NPV are 
given in Figure 11. Within the NSO (Fig. 11, A-C), silver grains 
were found to be distributed across all neurophysin-immuno- 
reactive cells. The highest density of grains was found to be 
localized to the ventral dendritic neuropil of the NSO, a region 
replete with immunofluorescent varicosities thought to be den- 
drites of the vasopressin and oxytocin magnocellular neurons 
(Armstrong et al., 1982). Grain density diminished sharply over 
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the glial cell layer along the basal lamina, in which few or no 
immunofluorescent varicosities were observed. 
The NC (Fig. 11, &) and magnocellular portions of the 
posterior lateral, anterior, and periventricular NPV (Fig. 11, G- 
I) were similar to the NSO, with silver grains appearing over 
the immunofluorescent cell bodies and processes. The density 
of grains in the core of the NC was as high as in the NSO, 
whereas the density in the NPV was much less. In contrast to 
the above, the binding of ‘251-aBTX in the NSC did not overlap 
with the neurophysin-immunoreactive cell bodies (Fig. 11, G- 
Z). The perimeter of the NSC was generally labeled, leaving the 
immunofluorescent cell bodies in the medial portion of the NSC 
unlabeled. 
Discussion 
As many as 3 different sites can be identified for the binding of 
lZSI-(rBTX to rat hypothalamus and brain stem membranes on 
the basis of differing affinities and kinetic properties. Each of 
these sites corresponds to an aBTX binding site that has been 
described previously. Saturation binding experiments by Schmidt 
(1977) and kinetically determined affinities by Lukas (1984b) 
have yielded Kds of 4-5 x 10-l’ M. Salvaterra et al. (1975) and 
Lukas (1984b) have observed both high- and low-affinity bind- 
ing sites in the same preparations with Kds of 0.9-5 x 1O-9 M 
and l-40 x 1O-8 M, respectively, for the high- and low-affinity 
sites. Other investigators have reported single affinities of 
l-5 x 1O-9 M for the binding of lz51-~BTX to brain membranes 
(Lukas, 1984a; Patrick and Stallcup, 1977b; Salvaterra et al., 
1975). Failure to observe more than one binding site can often 
be attributed to the use of a restricted range of ligand concen- 
trations or to the cation concentration of the binding buffer. 
The significance of each type of i251-aBTX binding remains 
to be determined, but a substantial body of existing data indi- 
cates that lz51-aBTX binds with high affinity to a nicotinic cho- 
linergic receptor-like polypeptide in rat brain. This binding is 
(1) on synaptosomes (Salvaterra et al., 1975), (2) associated with 
a protein with hydrodynamic properties and an isoelectric point 
similar to Torpedo nicotinic receptors (Lowy et al., 1976; Sal- 
vaterra and Mahler, 1976), (3) localized to the postsynaptic 
membrane (Hunt and Schmidt, 1978a; Lentz and Chester, 1977; 
Smolen, 1983; Vogel et al., 1977), (4) nonuniformly distributed 
in brain (Hunt and Schmidt, 1978b, Marks and Collins, 1982; 
Morley et al., 1977; Polz-Tejera et al., 1975; Segal et al., 1978; 
Silver and Billiar, 1976), and (5) able, in some cases, to be 
immunoprecipitated by antibodies to the purified nicotinic cho- 
linergic receptor (Block and Billiar, 1979; Conti-Tronconi et al., 
1985; Dolly and Barnard, 1984). 
The binding of various drugs in competition with lz51-aBTX 
is also consistent with that expected for a nicotinic cholinergic 
receptor, with d-tubocurarine, nicotine, and dimethylphenyl- 
piperazinium inhibiting the binding of 1251-~BTX at relatively 
low concentrations. Each compound interacted with both the 
high- and low-affinity ‘251-(uBTX binding sites. Inhibition of 
binding by ACh was particularly complex, as is illustrated by 
the heterogeneity of the competition curve. The shallow slope 
of the competition curve indicates that ACh recognizes 2 bind- 
ing sites, with estimated affinities of 3.6 x 1O-8 M and 7.4 x 
1O-5 M. Computer analysis of the ACh competition binding 
curve indicated that 3 1.4% of the total binding sites correspond- 
ed to high-affinity ACh binding, whereas 68.6% of the binding 
sites were of low affinity. This distribution of high- and low- 
affinity sites is similar to what would be predicted from the 
concentration of lZ51-~BTX (5 17 PM) used in the assay, given 
the K,, values obtained from the Scatchard analysis. Competition 
binding experiments in the presence of 150 mM Na+, where only 
a single ‘251-aBTX binding site can be discriminated, eliminated 
the high-affinity ACh interaction but increased the Hill slope 
only to a value of 0.53, suggesting that ACh was still interacting 
at 2 sites. Thus, it would appear that the high-affinity ACh 
binding may have corresponded to a low-affinity 12SI-aBTX 
binding site and that the heterogeneous ACh binding reflected 
in the competition curve was not simply a function of the com- 
plexity of the i251-~BTX interaction. 
Evidence indicating that several polypeptides in the CNS bind 
cholinergic ligands and that substantial variation may exist be- 
tween different types of tissue has been accumulating over the 
past several years. For example, multiple nicotinic cholinergic- 
like binding sites have been reported for 3H-nicotine (Roman0 
and Goldstein, 1980), 3H-dihydro-P-erythrodine (Williams and 
Robinson, 1984), as well as ‘251-aBTX (Lukas, 1984b; Salvaterra 
et al., 1975; Yazulla and Schmidt, 1977). Only a single binding 
site has been reported for 3H-ACh (Schwartz et al., 1982), but 
a site with a Kd greater than 1 O-* M could not have been measured 
because of high nonspecific binding. More biochemical char- 
acterization is needed to clearly evaluate the significance and 
interrelationships of each of these binding sites. Our data, in- 
dicating that lZ51-aBTX can bind specifically to 3 different bind- 
ing sites in rat brain, compare favorably with the observation 
of Betz et al. (1982) that ‘251-~BTX binds to 3 different poly- 
peptides isolated from chick retina. Only 1 of these polypeptides 
was similar in size to purified nAChR. The protein from rat 
brain that binds lZ51-~BTX can be 75% precipitated by anti- 
bodies to muscle nAChR, but not by antibodies to Torpedo 
nAChR (Mills and Wonnacott, 1984). Recently, Conti-Tron- 
coni et al. (1985) have demonstrated an ACh receptor from 
chick brain that is homologous, but not identical, to the muscle 
nicotinic ACh receptor. 
The binding of 1251-aBTX to rat brain membranes is highly 
sensitive to the Na+ concentration in the buffer. The sharp de- 
cline in binding as the buffer Na+ concentration increases ap- 
pears to be due to a decrease in the affinity of the 1251-aBTX for 
the high-affinity binding site, and possibly to a loss of the low- 
affinity binding site. All monovalent cations decrease the bind- 
ing of 1251-olBTX, indicating a general lack of cation specificity. 
The order of potency of the various cations does not predict a 
simple interaction of aBTX with the Na+ channel. The signif- 
icance of this cation sensitivity remains to be determined. 
To better understand the relationship between the vasopres- 
sin/oxytocin neuroendocrine system and its stimulation by pu- 
tative nicotinic cholinergic input, we have assessed the binding 
of 1251-~BTX to free-floating sections of 0.5% paraformalde- 
hyde-fixed hypothalamus under conditions that allow double- 
labeling with an immunocytochemical probe. With this ap- 
proach, it is clear that high-affinity binding sites for 1251-(uBTX 
are concentrated in the region of the NSO, NC, NPV, and NSC. 
Of these regions, the NSO contains the most striking concen- 
tration of lZ51-aBTX binding sites. The binding overlaps greatly 
with the localization of neurophysin-immunofluorescent peri- 
karya, particularly the ventral neuropil, which contains a dense 
network of dendrite-like processes extending from the vaso- 
pressin and oxytocin neurons of the NSO (Armstrong et al., 
1982; Yulis et al., 1984). These processes form a bundle that is 
sandwiched between the magnocellular perikarya of the NSO 
and a thin glial cushion that, along with the basal lamina, makes 
up the ventral surface of the brain. A high density of synaptic 
contacts (Armstrong et al., 1982) and catecholamine varicosities 
(McNeil1 and Sladek, 1980) within the ventral neuropil, as com- 
pared to that in the NSO (Leranth et al., 1975), suggests that 
much of the synaptic input to the cells of the NSO is mediated 
by contacts within the ventral neuropil. Many of the presynaptic 
terminals found contacting these processes contain round, clear 
vesicles similar to cholinergic endings (Yulis et al., 1984). 
A similar pattern of binding was apparent in the NC and 
NPV. The small groups of magnocellular neurons making up 
the NC contain either vasopressin or oxytocin (Rhodes et al., 
198 1) and are organized in a circular fashion around blood 
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vessels, with bundles of immunoreactive fibers following the 
vessel in the core of the nucleus. The present data helped to 
establish the NC as a possible primary target for cholinergic 
control of vasopressin/oxytocin secretion. The magnocellular 
neurons of the NPV also bound 12SI-aBTX but appeared to have 
a lower density of sites than those of the NSO or NC. Again, 
though, binding was associated exclusively with the regions of 
the NPV that contained neurophysin-immunoreactive cell bod- 
ies. 
The parvocellular vasopressin-containing cells of the NSC 
were a contrast to the magnocellular neurons of the NSO, NC 
and NPV. Although a relatively high concentration of binding 
sites was present in the region surrounding the NSC, little or no 
overlap with neurophysin-immunoreactive cell bodies was ob- 
served. Vasopressin fibers projecting dorsally from the NSC 
(Sofroniew and Weindl, 1978) or dendrites extending laterally 
from the ventral NSC (Stephan et al., 198 1; van den Pol, 1980) 
could be a potential target for cholinergic input. Assessment of 
this possibility will require closer examination of the 1251-aBTX 
binding site within this region. Some support for an interaction 
of a putative nicotinic cholinergic receptor with the NSC has 
been provided by the observation that cuBTX, applied locally 
to the region of the NSC, blocks the effects of light or cholinergic 
stimulation on serotonin-N-acetyltransferase activity in the pi- 
neal (Zatz and Brownstein, 198 1). 
Within the rostra1 hypothalamus, the magnocellular, neu- 
roendocrine cells of the NSO, NC, and NPV are associated with 
the highest density of high-affinity lz51-~BTX binding sites. The 
reason for this association is presently unknown but may reflect 
input from a nicotinic cholinergic system that is thought to 
control the release of vasopressin. Our findings supplement the 
recent work of Mason (1985) which illustrates staining of the 
NSO with a monoclonal antibody to the alpha subunit of the 
nicotinic cholinergic receptor of electric eel. The hypothalamic 
neuroendocrine system may be a model system for the clarifi- 
cation of the significance of the cvBTX binding site in brain, as 
well as for the understanding of the control of vasopressin se- 
cretion. 
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